BioStock Investor Meeting: Interview with OssDsign
In connection with the BioStock Investor Meeting in Stockholm, BioStock’s reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about OssDsign’s products for regenerative implants and patient-specific solutions for the treatment of bone defects. He also answered the question of what distinguishes OssDsign’s products from competitors and elaborated on the company’s road map for growth.
See the interview with OssDsign’s CFO Anders Svensson below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
